✦ LIBER ✦

A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD

✍ Scribed by James F. Donohue; Antonio Anzueto; Jean Brooks; Rashmi Mehta; Christopher Kalberg; Glenn Crater

Book ID: 116873233
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 989 KB
Volume: 106
Category: Article
ISSN: 0954-6111
DOI: 10.1016/j.rmed.2012.03.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, 6-week, dose

A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome

✍ Richard Allen; Crystal Chen; Adina Soaita; Christopher Wohlberg; Lloyd Knapp; Ba 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Golimumab in patients with active rheuma

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

✍ Jonathan Kay; Eric L. Matteson; Bhaskar Dasgupta; Peter Nash; Patrick Durez; Ste 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

A phase II, randomized, double-blind, pl

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

✍ Wallace, Daniel J. ;Stohl, William ;Furie, Richard A. ;Lisse, Jeffrey R. ;McKay, 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 2 views

## Abstract ## Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care therapy (SOC) in patients with active systemic lupus erythematosus (SLE). ## Methods Patients with a Safety of Estrogens in Lupus Erythematosus: National

Erratum: Golimumab in patients with acti

Erratum: Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

✍ Jonathan Kay; Eric L. Matteson; Bhaskar Dasgupta; Peter Nash; Patrick Durez; Ste 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

A Multicenter, Randomized, Double-Blind,

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of AST-120 (Kremezin) in Patients With Moderate to Severe CKD

✍ Gerald Schulman; Rajiv Agarwal; Muralidhar Acharya; Tomas Berl; Samuel Blumentha 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Efficacy and Safety of Darusentan in Pat

Efficacy and Safety of Darusentan in Patients With Resistant Hypertension: Results From a Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study

✍ Henry R. Black; George L. Bakris; Michael A. Weber; Robert Weiss; Mahfouz El Sha 📂 Article 📅 2007 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 246 KB